Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04553523 · ClinicalTrials.gov registry record · NA
Hydrus® Microstent New Enrollment Post-Approval Study
A NA study of Primary Open Angle Glaucoma, sponsored by Alcon Research.
- Recruiting
- Registry status
- NA
- Development phase
- 545
- Enrollment target
- 20
- Study locations
NCT04553523 is a NA study of Primary Open Angle Glaucoma that is actively recruiting participants, run by Alcon Research. The registered enrollment target is 545 participants, above the 266-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (105% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT04553523, a NA study of Primary Open Angle Glaucoma, is actively recruiting participants, sponsored by Alcon Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 545 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.
Conditions Studied
Interventions
- DEVICE Hydrus Microstent
- PROCEDURE Cataract surgery
- DEVICE Monofocal IOL
Study Locations (20)
Texas
- Texan Eye / Keystone Research - Austin
- Glaucoma Associates Of Texas - Dallas
- El Paso Eye Surgeons - El Paso
- Texas Eye Research Center - Hurst
Ohio
- Cleveland Eye Clinic - Brecksville
- Cincinnati Eye Institute - Cincinnati
- Cincinnati Eye / Apex Eye - Mason
California
- Coastal Vision - Irvine
- Sacramento Eye Consultants - Sacramento
Missouri
- Midwest Vision Research Foundation - Chesterfield
- Moyes Eye Center - Kansas City
Colorado
- Eye Center of Northern Colorado - Loveland
Iowa
- Jones Eye Center PC - Sioux City
Kansas
- Stiles Eyecare Excellence Cataracts and Glaucoma - Overland Park
Maryland
- Visionary Eye Doctors - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 545 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04553523
The ClinicalTrials.gov registry entry for NCT04553523 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 545 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 266-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (105% higher). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 3 interventions - of which Hydrus Microstent is the first listed.
NCT04553523 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Texas, Ohio, California.
Frequently Asked Questions
What is clinical trial NCT04553523 about?
NCT04553523 is a clinical study titled "Hydrus® Microstent New Enrollment Post-Approval Study". The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed b...
What is the current status of trial NCT04553523?
This trial is currently recruiting. It is a NA study. The enrollment target is 545 participants. The study started on 2020-08-25. Estimated completion is 2028-06.
What conditions does trial NCT04553523 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma.
What interventions are being tested in trial NCT04553523?
The interventions under investigation include: Hydrus Microstent (DEVICE), Cataract surgery (PROCEDURE), Monofocal IOL (DEVICE).
Who is sponsoring clinical trial NCT04553523?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04553523 being conducted?
This trial has 20 study locations across California, Colorado, Iowa, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
COMPLETED · NA
-
The Effects of Visior on Ocular Hemodynamics
COMPLETED · NA
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.